MedTrace Logo

Periodontal Disease and Post-menopausal Osteoporosis

NCT02184962 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 81

Last updated 2014-07-09

No results posted yet for this study

Summary

The aim of this study was to investigate the levels of RANKL and Osteoprotegerin, and their relationship in gingival crevicular fluid of post-menopausal women with osteoporosis/osteopenia and chronic periodontitis simultaneously and evaluate the effect that the use of bisphosphonates in periodontal disease.

Study hypothesis:

"The osteoporosis / osteopenia in postmenopausal women patients with periodontal disease affect the ratio RANKL / OPG in gingival crevicular fluid samples favoring osteoclastogenesis processes "

Conditions

Sponsors & Collaborators

  • Universidad Nacional de Córdoba

    lead OTHER

Principal Investigators

  • María E Verde, Odontóloga · Facultad de Odontología - UNC

Eligibility

Min Age
45 Years
Max Age
70 Years
Sex
FEMALE
Healthy Volunteers
No

Timeline & Regulatory

Start
2012-05-31
Primary Completion
2013-09-30
Completion
2013-09-30

Countries

  • Argentina

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02184962 on ClinicalTrials.gov